Published in BMJ on October 09, 1993
Mold allergens in respiratory allergy: from structure to therapy. Allergy Asthma Immunol Res (2015) 1.10
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice. Thorax (2014) 0.86
Injection immunotherapy. BMJ (1994) 0.75
Immunotherapy in asthma. Thorax (1997) 0.75
Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma. Lancet (1978) 2.51
Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ (1991) 2.32
Allergy to insect stings: a review. J R Soc Med (1985) 1.91
Immunotherapy of pollinosis in children: investigation of the immunologic basis of clinical improvement. N Engl J Med (1969) 1.42
Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy. J Allergy Clin Immunol (1982) 1.10
Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol (1990) 1.06
A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses. J Allergy Clin Immunol (1990) 0.99
Specific immunotherapy in asthma. J Allergy Clin Immunol (1990) 0.93
Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol (1985) 0.92
Measurement of IgG-blocking antibodies: development and application of a radioimmunoassay. J Immunol (1976) 0.91
Combination of passive and active immunization in honeybee venom immunotherapy. J Allergy Clin Immunol (1987) 0.90
Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. J Allergy Clin Immunol (1984) 0.89
A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy (1986) 0.88
Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol (1990) 0.88
Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract. Allergy (1979) 0.87
Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite. Clin Allergy (1988) 0.86
Immunotherapy with cat- and dog-dander extracts. II. In vivo and in vitro immunologic effects observed in a 1-year double-blind placebo study. J Allergy Clin Immunol (1986) 0.83
Venom immunotherapy: comparison of "rush" vs "conventional" schedules. Ann Allergy (1980) 0.83
The safety of allergenic immunotherapy. J Allergy Clin Immunol (1990) 0.82
Hyposensitization with a tyrosine adsorbed extract of Dermatophagoides pteronyssinus in adults with perennial rhinitis. A controlled clinical trial. Allergy (1984) 0.82
A double-blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac) in patients with perennial rhinitis. 1. Clinical aspects. Allergy (1989) 0.81
Quantitative relationships between IgE antibody and blocking antibodies specific for antigen E in patients given immunotherapy with ragweed antigen E. Clin Exp Immunol (1977) 0.81